Literature DB >> 28007518

Understanding falls in progressive supranuclear palsy.

Brent Bluett1, Irene Litvan2, Shumin Cheng3, Jorge Juncos4, David E Riley5, David G Standaert6, Stephen G Reich7, Deborah A Hall8, Benzi Kluger9, David Shprecher10, Connie Marras11, Joseph Jankovic12.   

Abstract

INTRODUCTION: Progressive supranuclear palsy (PSP) is characterized by frequent falls which worsen with disease progression, causing substantial morbidity and mortality. Few studies have investigated which factors contribute to falls in PSP, and all have involved few participants, thus lacking necessary statistical power. The aim of this study was to identify clinical parameters most significantly associated with increasing falls in PSP, using the largest sample of patients to date.
METHODS: Comprehensive clinical data were collected from 339 not demented PSP patients meeting the NINDS-SPSP criteria, who were divided into two groups - Infrequent Fallers (IF; n = 118) with rare falls, and Frequent Fallers (FF; n = 221) who fell occasionally to multiple times a day. Of 198 clinical parameters, we hypothesized 38 to be correlated with an increasing risk of falls. These 38 parameters were analyzed via univariate regression analysis to determine the strength of their association with fall frequency. Unit odds ratios identified the magnitude with which each parameter resulted in an increasing risk of falls.
RESULTS: Twenty-five of 38 parameters analyzed were significantly associated with fall frequency based on univariate analysis. Symptom duration, clinical measures of disease severity, and several motoric and oculomotor clinical parameters were associated with FF. Examined cognitive parameters and slowing of vertical saccades were not.
CONCLUSIONS: The clinical parameters identified as associated with increased frequency of falls improve our understanding of why they occur and may help identify not demented PSP patients at risk for increasing falls.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Balance; ENGENE; Falls; Parkinsonism; Postural instability; Progressive supranuclear palsy; Understanding

Mesh:

Year:  2016        PMID: 28007518     DOI: 10.1016/j.parkreldis.2016.12.009

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy.

Authors:  Farwa Ali; Stacy R Loushin; Hugo Botha; Keith A Josephs; Jennifer L Whitwell; Kenton Kaufman
Journal:  J Neurol Sci       Date:  2021-08-25       Impact factor: 4.553

2.  Gait initiation in progressive supranuclear palsy: brain metabolic correlates.

Authors:  Chiara Palmisano; Massimiliano Todisco; Giorgio Marotta; Jens Volkmann; Claudio Pacchetti; Carlo A Frigo; Gianni Pezzoli; Ioannis U Isaias
Journal:  Neuroimage Clin       Date:  2020-09-02       Impact factor: 4.881

3.  Enablers to Exercise Participation in Progressive Supranuclear Palsy: Health Professional Perspectives.

Authors:  Meg E Morris; Susan C Slade; Christopher Bruce; Jennifer L McGinley; Bastiaan R Bloem
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

4.  A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.

Authors:  Jianquan He; Xingxiang He; Yonghui Ma; Luxi Yang; Haiming Fang; Shu Shang; Huping Xia; Guanghui Lian; Hailing Tang; Qizhi Wang; Junping Wang; Zhihui Lin; Jianbo Wen; Yuedong Liu; Chunbao Zhai; Wen Wang; Xueliang Jiang; Ji Xuan; Morong Liu; Shiyun Lu; Xuejun Li; Han Wang; Cong Ouyang; Man Cao; Aiqiang Lin; Bangzhou Zhang; Depei Wu; Ye Chen; Chuanxing Xiao
Journal:  Microb Cell Fact       Date:  2021-11-27       Impact factor: 5.328

Review 5.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

Review 6.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 7.  Falls in Progressive Supranuclear Palsy.

Authors:  Fraser S Brown; James B Rowe; Luca Passamonti; Timothy Rittman
Journal:  Mov Disord Clin Pract       Date:  2019-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.